UK study finds vaccines offer high protection against hospitalisation from Delta variant

COVID-19 vaccines made by Pfizer and AstraZeneca offer high protection of more than 90% against hospitalisation from the Delta coronavirus variant, a new analysis by Public Health England showed on Monday. Prime Minister Boris Johnson is expected to announce a delay to the lifting of COVID-19 restrictions in England due to the spread of the highly transmissible Delta variant of concern, first identified in India, which is also associated with a higher risk of hospitalisation among the unvaccinated.